Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: A look at who's building health tech unicorns and how AI will shape the next wave
Amgen
Hospitals
AbbVie latest to impose 340B sales restrictions
AbbVie became the third drugmaker in recent months to impose restrictions on sales of 340B discounted drugs to contract pharmacies.
Robert King
Jan 5, 2022 9:30am
340B advocates urge federal enforcement as Amgen to cut access
Dec 2, 2021 7:05am
House Dems: 14 drugmakers spent $577B on buybacks, dividends
Jul 9, 2021 7:05am
HHS files appeal to keep plan for drug prices in TV ads alive
Aug 21, 2019 11:11am
Federal judge blocks HHS rule requiring list prices in drug TV ads
Jul 9, 2019 7:45am
Blue Cross of NC awards $2M to opioid epidemic projects—roundup
Jan 29, 2019 9:35pm
